AtriCure Operating Margin vs. Current Valuation
| ATRC Stock | USD 29.85 0.31 1.05% |
AtriCure Operating Profit Margin | -0.006771 |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.58 | 0.7441 |
|
|
Profitability metrics here describe how AtriCure converts revenue and assets into earnings and performance context.
Trending Equities. Macro event markers
Earnings Share -0.24 | Revenue Per Share | Quarterly Revenue Growth 0.131 | Return On Assets | Return On Equity |
AtriCure's market price can diverge from book value, the accounting figure shown on AtriCure's balance sheet. AtriCure's market capitalization is 1.49 B. With a P/B ratio of 3.02, the market values AtriCure well above its book equity. Enterprise value stands at 1.39 B. Value and price for AtriCure are related but not identical, and they can diverge across cycles. Trading price represents the transaction level agreed by market participants.
Note that AtriCure's intrinsic value and market price are different measures derived from different inputs. For AtriCure, key inputs include a P/E ratio of 33.47, a P/B ratio of 3.02, a profit margin of -2.14%, and ROE of -2.4%. The quoted AtriCure price is the exchange level where supply meets demand.
AtriCure Current Valuation vs. Operating Margin Fundamental Analysis
Sector multiples frame AtriCure's current valuation context. AtriCure holds the #5 position for operating margin relative to top peers. It also holds the #5 position for current valuation relative to top peers with a Current Valuation-to-Operating Margin ratio near 78,673,982,768 . Over the last reporting cycle, Operating Profit Margin is aligned with a recovering pattern. The previous fiscal year placed Operating Profit Margin at -0.0064. Relative ratio analysis evaluates AtriCure's earnings valuation.AtriCure's Historical Earnings Breakdown by Geography
AtriCure Current Valuation vs. Operating Margin
Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
AtriCure |
| = | 0.02 % |
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
AtriCure |
| = | 1.39 B |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
AtriCure Current Valuation vs Competition
AtriCure holds the #5 position for current valuation relative to top peers. After adjusting for long-term liabilities, total market size of Health Care industry is presently estimated at about 20.15 Billion. AtriCure holds roughly 1.39 Billion in current valuation claiming about 7% of equities under Health Care sector.
AtriCure Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in AtriCure, profitability is also one of the essential criteria for including it into their portfolios because, without profit, AtriCure will eventually generate negative long term returns. The profitability progress is the general direction of AtriCure's change in net profit over the period of time. It can combine multiple indicators of AtriCure, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 566 K | 594.3 K | |
| Operating Income | -3.4 M | -3.6 M | |
| Total Other Income Expense Net | -6.7 M | -6.4 M | |
| Net Loss | -11.4 M | -12 M | |
| Income Tax Expense | 1.3 M | 874.8 K | |
| Income Before Tax | -10.2 M | -10.7 M | |
| Net Loss | -11.4 M | -12 M | |
| Non Operating Income Net Other | 1.7 M | 1.8 M | |
| Net Loss | -41.8 M | -39.7 M | |
| Interest Income | 4.5 M | 4.7 M | |
| Net Interest Income | -1.4 M | -1.5 M | |
| Change To Netincome | 26.6 M | 27.9 M | |
| Net Loss | -0.24 | -0.25 | |
| Income Quality | -5.76 | -5.47 | |
| Net Income Per E B T | 1.13 | 0.81 |
AtriCure Profitability Driver Comparison
Understanding AtriCure's profitability drivers is a critical part of evaluating AtriCure as an investment. Unexpected events - from regulatory changes to commodity price movements - can materially alter the profit trajectory and investment outlook during any given holding period.
Earnings per Share Projection vs Actual
Use AtriCure in pair-trading
A pair strategy built around AtriCure is useful when investors want to reduce directional market exposure while still expressing a relative-value idea. This framework is most useful when investors want to hedge directional moves caused by sector headlines or broad market pressure.
AtriCure Pair Trading
AtriCure Pair Trading Analysis
Identifying correlated replacements for AtriCure is particularly important in concentrated portfolios where AtriCure represents a large allocation. A poor substitute could introduce unintended factor or sector risks that persist beyond the required waiting period.
Correlation is not causation, but for AtriCure it is a practical tool. High correlations between AtriCure and a potential addition to the portfolio flag concentrated exposure, while low correlations signal diversification potential.
Use Correlation analysis and pair trading evaluation for AtriCure to review hedging context. The approach can be applied within sectors or across broader universes.Use Investing Themes to Complement your AtriCure position
AtriCure operates in Healthcare/Medical Instruments & Supplies at 1.49 Billion market cap - a thematic view expands this smaller-cap position into a broader portfolio concept. AtriCure smaller-cap scale (1.49 Billion) within Medical Instruments & Supplies helps compare substitutes, complements, and diversifiers that strengthen the overall Healthcare allocation.
Did You Try This Idea?
Run Small Value Funds Thematic Idea Now
Small Value Funds
Funds or Etfs that invest in the undervalued stocks of small to mid-sized companies. The Small Value Funds theme has 48 constituents at this time.
Whether used as a passive allocation or an active trading idea, the Small Value Funds Theme provides a structured starting point for portfolio construction.
| View All Next | Launch |
More Resources for AtriCure Stock Analysis
Reviewing AtriCure commonly begins with financial statements and performance trends. Ratio analysis helps investors evaluate AtriCure Stock operating efficiency and financial trajectory. Highlighted below are reports that provide context for AtriCure Stock:Trending Equities. Our How to Buy AtriCure Stock guide explains the steps to invest in AtriCure stock.AtriCure at P/E 33.47 and ROE -2.4% (1.49 Billion market cap) - this analysis works best as a complementary layer when evaluating how the position fits in a broader portfolio. That valuation within Healthcare invites comparison with Medical Instruments & Supplies peers using the tools below to judge whether the multiple is justified. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Projecting AtriCure's profitability starts with historical financial statements. Core statements include the income statement, balance sheet, and cash-flow statement.